Maolac no longer wants to be thought of as ‘the colostrum company’, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.
Maolac 2.0: Start-up looks to fungi and plant side streams for breast milk protein biosimilarity
2023-04-02 15:16
Portfolio Companies
